{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:15:10Z","timestamp":1787062510544,"version":"build-2736575974"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"11","funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT23RC(3)055"],"award-info":[{"award-number":["DUT23RC(3)055"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT23RC(3)061"],"award-info":[{"award-number":["DUT23RC(3)061"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province","award":["FYYFEJB2024003"],"award-info":[{"award-number":["FYYFEJB2024003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the anti-pancreatic ductal adenocarcinoma (PDAC) effect of mesoporous silica nanoparticles loaded with berberine (MSN-BBR) both in vitro and in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Disulfide-bridged MSN loaded with berberine (BBR) was synthesized and characterized. The study assessed the anti-PDAC effect and the impact on the stemness of pancreatic cancer stem cells (PCSCs) in Panc1 cells and mice. Pathological morphology in the pancreas of mice was evaluated through immunohistochemical and immunofluorescence staining, while protein expressions were analyzed via western blot.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>MSN-BBR glutathione-degraded and released BBR. Moreover, MSN-BBR demonstrated the inhibition of Panc1 cell viability and the stemness ability of PCSC by suppressing the epithelial-mesenchymal transition (EMT) pathway. Consistent with these cellular outcomes, MSN-BBR also impeded the growth of pancreatic tumors by specifically targeting PCSC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MSN-BBR exhibited degradation and BBR release ability. Notably, MSN-BBR exhibited enhanced efficacy in combating PDAC by selectively focusing on PCSC compared to BBR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgaf058","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T10:07:35Z","timestamp":1752746855000},"page":"1534-1541","source":"Crossref","is-referenced-by-count":3,"title":["Berberine-loaded mesoporous silica nanomaterials inhibit pancreatic cancer targeting cancer stem cells"],"prefix":"10.1093","volume":"77","author":[{"given":"Xihuang","family":"Cao","sequence":"first","affiliation":[{"name":"The Second Hospital of Dalian Medical University , Dalian, 116027 ,","place":["China"]},{"name":"Central Hospital of Dalian University of Technology , Dalian, 116033 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyuan","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalian University of Technology , Dalian, 116023 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5690-194X","authenticated-orcid":false,"given":"Yanping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalian University of Technology , Dalian, 116023 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalian University of Technology , Dalian, 116023 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalian University of Technology , Dalian, 116023 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of China Medical University , Shenyang, 110001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuwen","family":"Luo","sequence":"additional","affiliation":[{"name":"The Second Hospital of Dalian Medical University , Dalian, 116027 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalian University of Technology , Dalian, 116023 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"2025110409541114300_ref1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms18071338","article-title":"Pancreatic ductal adenocarcinoma: current and evolving therapies","volume":"18","author":"Adamska","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2025110409541114300_ref2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.semcancer.2019.08.022","article-title":"Functionalized mesoporous silica nanoparticles in anticancer therapeutics","volume":"69","author":"Barkat","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"2025110409541114300_ref3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22094765","article-title":"Pancreatic cancer and therapy: role and regulation of cancer stem cells","volume":"22","author":"Barman","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025110409541114300_ref4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1208\/s12249-022-02241-9","article-title":"In vitro and In vivo evaluations of berberine-loaded microparticles filled In-house 3D printed hollow capsular device for improved oral bioavailability","volume":"23","author":"Chomudhury","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"2025110409541114300_ref5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-319-41334-1_2","article-title":"Berberine and its role in chronic disease","volume":"928","author":"Cicero","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"2025110409541114300_ref6","doi-asserted-by":"publisher","first-page":"2074610","DOI":"10.1155\/2021\/2074610","article-title":"The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials","volume":"2021","author":"Guo","year":"2021","journal-title":"Oxidative Med Cell Longev"},{"key":"2025110409541114300_ref7","doi-asserted-by":"publisher","first-page":"104722","DOI":"10.1016\/j.phrs.2020.104722","article-title":"Berberine pharmacology and the gut microbiota: a hidden therapeutic link","volume":"155","author":"Habtemariam","year":"2020","journal-title":"Pharmacol Res"},{"key":"2025110409541114300_ref8","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/ptr.7407","article-title":"Berberine as a natural modulator of inflammatory signaling pathways in the immune system: focus on NF-kappaB, JAK\/STAT, and MAPK signaling pathways","volume":"36","author":"Hafcheshmeh","year":"2022","journal-title":"Phytother Res"},{"key":"2025110409541114300_ref9","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3389\/fphar.2018.01150","article-title":"Berberine attenuated proliferation, invasion and migration by targeting the AMPK\/HNF4alpha\/WNT5A pathway in gastric carcinoma","volume":"9","author":"Hu","year":"2018","journal-title":"Front Pharmacol"},{"key":"2025110409541114300_ref10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2023.05.036","article-title":"The immune microenvironment in pancreatic cancer","volume":"165","author":"Huber","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025110409541114300_ref11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","article-title":"Strategies to improve the EPR effect: a mechanistic perspective and clinical translation","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"J Control Release"},{"key":"2025110409541114300_ref12","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1200\/JCO.2008.16.6702","article-title":"Pancreatic cancer stem cells","volume":"26","author":"Lee","year":"2008","journal-title":"J Clin Oncol"},{"key":"2025110409541114300_ref13","doi-asserted-by":"publisher","first-page":"174680","DOI":"10.1016\/j.ejphar.2021.174680","article-title":"Berberine inhibits pancreatic intraepithelial neoplasia by inhibiting glycolysis via the adenosine monophosphate -activated protein kinase pathway","volume":"915","author":"Liu","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"2025110409541114300_ref14","doi-asserted-by":"publisher","first-page":"106440","DOI":"10.1016\/j.phrs.2022.106440","article-title":"Berberine for gastric cancer prevention and treatment: multi-step actions on the Correa's cascade underlie its therapeutic effects","volume":"184","author":"Liu","year":"2022","journal-title":"Pharmacol Res"},{"key":"2025110409541114300_ref15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fphar.2022.814871","article-title":"Therapeutic effects of berberine on liver fibrosis are associated with lipid metabolism and intestinal Flora","volume":"2","author":"Liu","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025110409541114300_ref16","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/jpp\/rgac026","article-title":"Berberine suppresses the migration and invasion of colon cancer cells by inhibition of lipogenesis through modulation of promyelocytic leukemia zinc finger-mediated sterol-regulatory element binding proteins cleavage-activating protein ubiquitination","volume":"74","author":"Liu","year":"2022","journal-title":"J Pharm Pharmacol"},{"key":"2025110409541114300_ref17","doi-asserted-by":"publisher","first-page":"eaay7148","DOI":"10.1126\/sciadv.aay7148","article-title":"Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers","volume":"6","author":"Dawulieti","year":"2020","journal-title":"Sci Adv"},{"key":"2025110409541114300_ref18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.32604\/biocell.2022.018278","article-title":"Cetyltrimethylammonium bromide inhibits the metastasis of breastcancer to the lungs by inhibiting epithelial-mesenchymal transition.","volume-title":"Biocell","author":"Ning","year":"2022"},{"key":"2025110409541114300_ref19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ph15101199","article-title":"Berberine overcomes gemcitabine-associated chemoresistance through regulation of Rap1\/PI3K-Akt Signaling in pancreatic ductal adenocarcinoma","volume":"15","author":"Okuno","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"2025110409541114300_ref20","doi-asserted-by":"publisher","first-page":"917827","DOI":"10.3389\/fphar.2022.917827","article-title":"Berberine suppresses lung metastasis of cancer via inhibiting endothelial transforming growth factor Beta receptor 1","volume":"13","author":"Tian","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025110409541114300_ref21","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3389\/fphar.2020.00666","article-title":"Obg-like ATPase 1 enhances chemoresistance of breast cancer via activation of TGF-\u03b2\/Smad axis cascades","volume":"11","author":"Liu","year":"2020","journal-title":"Front Pharmacol"},{"key":"2025110409541114300_ref22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/adma.201801198","article-title":"Bioinspired Diselenide-bridged mesoporous silica nanoparticles for dual-responsive protein delivery","volume":"30","author":"Shao","year":"2018","journal-title":"Adv Mater"},{"key":"2025110409541114300_ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-023-11571-1","article-title":"Circular rna znf800 (hsa_circ_0082096) regulates cancer stem cell properties and tumor growth in colorectal cancer","volume":"23","author":"Rengganaten","year":"2023","journal-title":"BMC Cancer"},{"key":"2025110409541114300_ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines11041040","article-title":"Cancer stem cell markers, sox 2 and oct 4 in ameloblastoma and keratocystic odontogenic tumor: an immunohistochemical study","volume":"11","author":"Bandyopadhyay","year":"2017","journal-title":"J Int Oral Health"},{"key":"2025110409541114300_ref25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040541","article-title":"Low cd8+ t cell infiltration and high pd-l1 expression are associated with level of cd44+\/cd133+ cancer stem cells and predict an unfavorable prognosis in pancreatic cancer","volume":"11","author":"Hou","year":"2019","journal-title":"Cancers"},{"key":"2025110409541114300_ref26","first-page":"653","article-title":"Hypoxic conditions promote gemcitabine sensitivity in a pancreatic cancer stem cell line","volume":"36","author":"Imaizumi","year":"2016","journal-title":"Anticancer Res"},{"key":"2025110409541114300_ref27","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1097\/MPA.0000000000001934","article-title":"MicroRNAs in pancreatic cancer and chemoresistance","volume":"50","author":"Pan","year":"2021","journal-title":"Pancreas."},{"key":"2025110409541114300_ref28","doi-asserted-by":"publisher","first-page":"794","DOI":"10.7150\/ijbs.18969","article-title":"Berberine reverses hypoxia-induced chemoresistance in breast cancer through the inhibition of AMPK- HIF-1alpha","volume":"13","author":"Pan","year":"2017","journal-title":"Int J Biol Sci"},{"key":"2025110409541114300_ref29","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.7150\/jca.19106","article-title":"Berberine enhances chemosensitivity and induces apoptosis through dose-orchestrated AMPK Signaling in breast cancer","volume":"8","author":"Pan","year":"2017","journal-title":"J Cancer"},{"key":"2025110409541114300_ref30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/nu13103665","article-title":"Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with polycystic ovary syndrome: a one-group pretest-post-test explanatory study","volume":"13","author":"Rondanelli","year":"2021","journal-title":"Nutrients."},{"key":"2025110409541114300_ref31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/DDDT.S156123","article-title":"Berberine nanoparticles with enhanced in vitro bioavailability: characterization and antimicrobial activity","volume":"12","author":"Sahibzada","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"2025110409541114300_ref32","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.2147\/IJN.S174072","article-title":"Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems","volume":"13","author":"Marziyeh","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"2025110409541114300_ref33","doi-asserted-by":"publisher","first-page":"e2004385","DOI":"10.1002\/adma.202004385","article-title":"Biomimetic diselenide-bridged mesoporous organosilica nanoparticles as an X-ray-responsive biodegradable carrier for chemo-immunotherapy","volume":"32","author":"Shao","year":"2020","journal-title":"Adv Mater"},{"key":"2025110409541114300_ref34","doi-asserted-by":"publisher","first-page":"100294","DOI":"10.1016\/j.cobme.2021.100294","article-title":"Janus metallic mesoporous silica nanoparticles: unique structures for cancer theranostics","volume":"19","author":"Shao","year":"2021","journal-title":"Curr Opin Biomed Eng"},{"key":"2025110409541114300_ref35","doi-asserted-by":"publisher","first-page":"794","DOI":"10.7150\/ijbs.18969","article-title":"Berberine reverses hypoxia-induced chemoresistance in breast cancer through the inhibition of AMPK-HIF-1\u03b1","volume":"13","author":"Pan","year":"2017","journal-title":"Int J Biol Sci"},{"key":"2025110409541114300_ref36","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.7150\/jca.19106","article-title":"Berberine enhances chemosensitivity and induces apoptosis through dose-orchestrated AMPK Signaling in breast cancer","volume":"8","author":"Pan","year":"2017","journal-title":"J Cancer"},{"key":"2025110409541114300_ref37","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics."},{"key":"2025110409541114300_ref38","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","article-title":"Biological properties and clinical applications of berberine","volume":"14","author":"Song","year":"2020","journal-title":"Front Med"},{"key":"2025110409541114300_ref39","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1080\/21655979.2021.1987130","article-title":"Berberine inhibited carotid atherosclerosis through PI3K\/AKTmTOR signaling pathway","volume":"12","author":"Song","year":"2021","journal-title":"Bioengineered"},{"key":"2025110409541114300_ref40","doi-asserted-by":"publisher","first-page":"110984","DOI":"10.1016\/j.biopha.2020.110984","article-title":"Therapeutic effect of berberine on metabolic diseases: both pharmacological data and clinical evidence","volume":"133","author":"Xu","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"2025110409541114300_ref41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms20184504","article-title":"Chemoresistance in pancreatic cancer","volume":"20","author":"Zeng","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025110409541114300_ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173887","article-title":"Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1","volume":"895","author":"Zhao","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"2025110409541114300_ref43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-017-0624-9","article-title":"The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer","volume":"16","author":"Zhou","year":"2017","journal-title":"Mol Cancer"},{"key":"2025110409541114300_ref44","doi-asserted-by":"publisher","first-page":"289264","DOI":"10.1155\/2014\/289264","article-title":"Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus","volume":"2014","author":"Li","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"2025110409541114300_ref45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.molimm.2016.04.011","article-title":"Berberine inhibits inflammatory mediators and attenuates acute pancreatitis through deactivation of JNK signaling pathways","volume":"74","author":"Choi","year":"2016","journal-title":"Mol Immunol"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/11\/1534\/63990477\/rgaf058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/11\/1534\/63990477\/rgaf058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:54:19Z","timestamp":1762268059000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/77\/11\/1534\/8228273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,8,8]]},"published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgaf058","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,8,8]]}}}